Table 1.
The MCM6 mRNA relative expression and clinical information of 31 neuroblastoma tissue samples
| MCM6 expression | Total | P value | ||
|---|---|---|---|---|
| Low | High | |||
| Sex | 0.071 | |||
| Male | 8 | 10 | 18 | |
| Female | 10 | 3 | 13 | |
| Age at diagnosis | 0.008 | |||
| ≤ 18 m | 1 | 6 | 7 | |
| > 18 m | 17 | 7 | 24 | |
| Stage | 0.484 | |||
| I, II, IVs | 2 | 4 | 6 | |
| III, IV | 8 | 8 | 16 | |
| Primary site | 0.768 | |||
| Retroperitoneum | 5 | 3 | 10 | |
| Postmediastinum | 13 | 10 | 21 | |
| Hisopathology diagnosis | 0.000 | |||
| GN | 8 | 1 | 9 | |
| GNB | 8 | 0 | 8 | |
| NB | 2 | 12 | 14 | |
| Bone marrow metastasis | 0.841 | |||
| Positive | 2 | 1 | 3 | |
| Negative | 17 | 11 | 28 | |
| Risk | 0.396 | |||
| Low | 11 | 5 | 16 | |
| Mid | 3 | 1 | 4 | |
| High | 5 | 6 | 11 | |
The value is displayed as the number of cases. NB neurobastoma, GNB ganglioeuroblastoma, GN ganglioneuroma